Green Growth Brands Inc. (CNSX:GGB) announced review of strategic alternatives. Green Growth Brands Inc. announced that The BRN Group Inc. ("BRN") has agreed to acquire (the "CBD Transaction") the company's cannabidiol business (the "CBD Business"). In connection with the CBD Transaction, the company has formed a special committee ("Special Committee") of directors to explore a full range of strategic alternatives with respect the CBD Business. The Special Committee's mandate includes overseeing the negotiation of definitive documentation in connection with the CBD Transaction, any competing proposal or other potential transaction, soliciting, evaluating and negotiating any competing offers, pursuing potential sources of financing and considering a full range of strategic alternatives in relation to the business of the Company and potential cost saving measures and other operational efficiencies. At the recommendation of the Special Committee, the Company has retained AltaCorp Capital Inc. as its financial advisor to run a sales process (the "CBD Sales Process") during the Go Shop Period on behalf of the Company. The Company expects that the net proceeds, if any, of any transaction in respect of the CBD Business would be used primarily to satisfy obligations of the Company and its subsidiaries and for general working capital purposes and to ensure that the Company continues as a going concern. There can be no assurance that the CBD Transaction or any other transaction in respect of the CBD Business will be completed, or the broader strategic review and CBD Sales Process will result in the completion of any particular transaction or outcome or result in specific measures to conserve cash as the Company addresses its ability to meet its obligations in the near term.